Filed: 8/13/2026ACC: 0001193125-26-349398
📋 What this filing means
EQT FUND MANAGEMENT S.A R.L. filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $862.62M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$862.62M
Total AUM (reported)
45.68M
Total Shares
Allocation by class
COM$629.20M72.9%
ORDINARY SHARES$96.40M11.2%
COM SHS$70.28M8.1%
SPONSORED ADS$66.74M7.7%
Portfolio Concentration
Top 3$725.60M84.1%
4–10$137.02M15.9%
Top 3 weight
84.1%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 45.68M
Sole
Full voting authority
45.68M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
WAYSTAR HLDG CORP
SOLEShares24.88M
TypeSH
Market value$510.77M
59.21%
Sole
24.88M
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares3.42M
TypeSH
Market value$118.42M
13.73%
Sole
3.42M
Shared
0.00
None
0.00
OCULIS HOLDING AG
SOLEShares6.95M
TypeSH
Market value$96.40M
11.18%
Sole
6.95M
Shared
0.00
None
0.00
EVOMMUNE INC
SOLEShares5.29M
TypeSH
Market value$70.28M
8.15%
Sole
5.29M
Shared
0.00
None
0.00
AGOMAB THERAPEUTICS NV
SOLEShares5.14M
TypeSH
Market value$66.74M
7.74%
Sole
5.14M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
WAYSTAR HLDG CORPSOLE | COM | 24.88M | SH | $510.77M 59.21% | 24.88M | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 3.42M | SH | $118.42M 13.73% | 3.42M | 0.00 | 0.00 |
OCULIS HOLDING AGSOLE | ORDINARY SHARES | 6.95M | SH | $96.40M 11.18% | 6.95M | 0.00 | 0.00 |
EVOMMUNE INCSOLE | COM SHS | 5.29M | SH | $70.28M 8.15% | 5.29M | 0.00 | 0.00 |
AGOMAB THERAPEUTICS NVSOLE | SPONSORED ADS | 5.14M | SH | $66.74M 7.74% | 5.14M | 0.00 | 0.00 |